person · Reporting owner

Barry James Christopher

Disclosed activity across 2 companies

Tapewire entity: 37274
SEC CIK: 0001756949

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
LivaNova PLCLIVN · Entity 507	Director	June 15, 2026	June 17, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LivaNova PLC

Report date June 15, 2026 · Filed June 17, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	7,918	Ending reported balance After 2026-06-15 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-06-15 · Exercise / conversion · Acquired 4,042 · Balance 8,404 F1: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. Row 2 · 2026-06-15 · Tax withholding · Disposed 486 · Balance 7,918 F3: Shares withheld to satisfy tax liability.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-06-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-06-15 · Exercise / conversion · Disposed 4,042 · Balance 0 F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F4: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	2,383	Reported balance After 2026-06-15 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-06-15 · Grant · Acquired 2,383 · Balance 2,383 F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F5: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F3: Shares withheld to satisfy tax liability.

F4: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026.

F5: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

NUVASIVE INC

Report date September 01, 2023 · Filed September 05, 2023

Section 16 reporting ended · disclosed 2023-09-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common Stock, par value $0.001 per shareSEC Table I · non-derivative	Direct	Reported balance After 2023-09-01 transaction · row 1 1 source row Row 1 · 2023-09-01 · Disposition to issuer · Disposed 72,997 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus ("Globus Class A Common Stock"), par value $0.001 per share (the "Exchange Ratio" and such shares, the "Merger Consideration"), and cash in lieu of fractional shares.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-09-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-09-01 · Disposition to issuer · Disposed 38,199 · Balance 0 F2: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F3: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-09-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-09-01 · Disposition to issuer · Disposed 45,864 · Balance 0 F2: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F3: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-09-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-09-01 · Disposition to issuer · Disposed 120,694 · Balance 0 F2: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F3: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time.
Performance Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-09-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-09-01 · Disposition to issuer · Disposed 38,199 · Balance 0 F2: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F4: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time.
Performance Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-09-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-09-01 · Disposition to issuer · Disposed 45,864 · Balance 0 F2: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F4: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus ("Globus Class A Common Stock"), par value $0.001 per share (the "Exchange Ratio" and such shares, the "Merger Consideration"), and cash in lieu of fractional shares.

F2: Represented a contingent right to receive one share of the Issuer's common stock upon vesting.

F3: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time.

F4: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 15, 2026 Filed Jun 17, 2026 20:09 UTC	LivaNova PLC LIVN · Entity 507	GrantRestricted Stock Units · Derivative	2,383	$0.00	$0.00	Disclosure SEC source: 0001639691-26-000073 · wk-form4_1781726956.xml · derivative · entry 4 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,383 Underlying: Ordinary Shares · 2,383 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F5 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F5 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:09 UTC	LivaNova PLC LIVN · Entity 507	Exercise / conversionRestricted Stock Units · Derivative	4,042	$0.00	$0.00	Disclosure SEC source: 0001639691-26-000073 · wk-form4_1781726956.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. F4 · derivative.expiration_date: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:09 UTC	LivaNova PLC LIVN · Entity 507	Tax withholdingOrdinary Shares	486	$79.70	$38,734.20	Disclosure SEC source: 0001639691-26-000073 · wk-form4_1781726956.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,918 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:09 UTC	LivaNova PLC LIVN · Entity 507	Exercise / conversionOrdinary Shares	4,042	$0.00	$0.00	Disclosure SEC source: 0001639691-26-000073 · wk-form4_1781726956.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC	LivaNova PLC LIVN · Entity 507	GrantRestricted Stock Units · Derivative	4,042	$0.00	$0.00	Disclosure SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · derivative · entry 4 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC	LivaNova PLC LIVN · Entity 507	Exercise / conversionRestricted Stock Units · Derivative	3,416	$0.00	$0.00	Disclosure SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC	LivaNova PLC LIVN · Entity 507	Tax withholdingOrdinary Shares	410	$45.76	$18,761.60	Disclosure SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,362 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC	LivaNova PLC LIVN · Entity 507	Exercise / conversionOrdinary Shares	3,416	$0.00	$0.00	Disclosure SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document
December 15, 2024 Filed Dec 17, 2024 22:22 UTC	LivaNova PLC LIVN · Entity 507	Exercise / conversionRestricted Stock Units · Derivative	1,709	$0.00	$0.00	Disclosure SEC source: 0001639691-24-000149 · wk-form4_1734474167.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,709 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement. F4 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document
December 15, 2024 Filed Dec 17, 2024 22:22 UTC	LivaNova PLC LIVN · Entity 507	Tax withholdingOrdinary Shares	353	$51.50	$18,179.50	Disclosure SEC source: 0001639691-24-000149 · wk-form4_1734474167.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,356 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document
December 15, 2024 Filed Dec 17, 2024 22:22 UTC	LivaNova PLC LIVN · Entity 507	Exercise / conversionOrdinary Shares	1,709	$0.00	$0.00	Disclosure SEC source: 0001639691-24-000149 · wk-form4_1734474167.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Read SEC document
June 15, 2024 Filed Jun 18, 2024 20:06 UTC	LivaNova PLC LIVN · Entity 507	GrantRestricted Stock Units · Derivative	3,416	$0.00	$0.00	Disclosure SEC source: 0001639691-24-000100 · wk-form4_1718741210.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F2 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:33 UTC	LivaNova PLC LIVN · Entity 507	GrantRestricted Stock Units · Derivative	1,709	$0.00	$0.00	Disclosure SEC source: 0001639691-23-000121 · wk-form4_1703021602.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,709 Underlying: Ordinary Shares · 1,709 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F2 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on December 15, 2024, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on December 15, 2024, subject to continued service during the vesting period and the award agreement. Read SEC document
September 01, 2023 Filed Sep 5, 2023 16:30 UTC	NUVASIVE INC NUVA · Entity 110002	Disposition to issuerPerformance Restricted Stock Unit · Derivative	45,864	$0.00	$0.00	Disclosure SEC source: 0001209191-23-048164 · doc4.xml · derivative · entry 6 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,864 shares Expires not disclosed F2 · derivative.exercise_price: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time. Read SEC document
September 01, 2023 Filed Sep 5, 2023 16:30 UTC	NUVASIVE INC NUVA · Entity 110002	Disposition to issuerPerformance Restricted Stock Unit · Derivative	38,199	$0.00	$0.00	Disclosure SEC source: 0001209191-23-048164 · doc4.xml · derivative · entry 5 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,199 shares Expires not disclosed F2 · derivative.exercise_price: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time. Read SEC document
September 01, 2023 Filed Sep 5, 2023 16:30 UTC	NUVASIVE INC NUVA · Entity 110002	Disposition to issuerRestricted Stock Unit · Derivative	120,694	$0.00	$0.00	Disclosure SEC source: 0001209191-23-048164 · doc4.xml · derivative · entry 4 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,694 shares Expires not disclosed F2 · derivative.exercise_price: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time. Read SEC document
September 01, 2023 Filed Sep 5, 2023 16:30 UTC	NUVASIVE INC NUVA · Entity 110002	Disposition to issuerRestricted Stock Unit · Derivative	45,864	$0.00	$0.00	Disclosure SEC source: 0001209191-23-048164 · doc4.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,864 shares Expires not disclosed F2 · derivative.exercise_price: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time. Read SEC document
September 01, 2023 Filed Sep 5, 2023 16:30 UTC	NUVASIVE INC NUVA · Entity 110002	Disposition to issuerRestricted Stock Unit · Derivative	38,199	$0.00	$0.00	Disclosure SEC source: 0001209191-23-048164 · doc4.xml · derivative · entry 2 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,199 shares Expires not disclosed F2 · derivative.exercise_price: Represented a contingent right to receive one share of the Issuer's common stock upon vesting. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio. Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time. Read SEC document
September 01, 2023 Filed Sep 5, 2023 16:30 UTC	NUVASIVE INC NUVA · Entity 110002	Disposition to issuerCommon Stock, par value $0.001 per share	72,997	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-23-048164 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus ("Globus Class A Common Stock"), par value $0.001 per share (the "Exchange Ratio" and such shares, the "Merger Consideration"), and cash in lieu of fractional shares. Read SEC document
March 01, 2023 Filed Mar 3, 2023 17:45 UTC	NUVASIVE INC NUVA · Entity 110002	GrantRSUs · Derivative	120,694	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-23-015840 · doc4.xml · derivative · entry 4 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,694 Underlying: Common Stock · 120,694 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2023. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2026. F5 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2023. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2026. Read SEC document
March 01, 2023 Filed Mar 3, 2023 17:45 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionRSUs · Derivative	34,284	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-23-015840 · doc4.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,284 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award vested as to 34,284 shares on March 1, 2023. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award vested as to 34,284 shares on March 1, 2023. Read SEC document
March 01, 2023 Filed Mar 3, 2023 17:45 UTC	NUVASIVE INC NUVA · Entity 110002	Tax withholdingCommon Stock	11,505	$42.67	$490,918.35	Disclosure SEC source: 0001209191-23-015840 · doc4.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,997 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
March 01, 2023 Filed Mar 3, 2023 17:45 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionCommon Stock	34,284	$0.00	$0.00	Disclosure SEC source: 0001209191-23-015840 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
April 13, 2022 Filed Apr 15, 2022 17:49 UTC	NUVASIVE INC NUVA · Entity 110002	SaleCommon Stock	5,000	$58.00	$290,000.00	Disclosure SEC source: 0001209191-22-024530 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,218 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
March 28, 2022 Filed Mar 30, 2022 17:50 UTC	NUVASIVE INC NUVA · Entity 110002	SaleCommon Stock	5,000	$55.00	$275,000.00	Disclosure SEC source: 0001209191-22-021639 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,218 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	GrantRSUs · Derivative	45,864	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-22-015756 · doc4.xml · derivative · entry 5 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,864 Underlying: Common Stock · 45,864 shares Expires not disclosed F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025. F7 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025. Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionRSUs · Derivative	34,200	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-22-015756 · doc4.xml · derivative · entry 4 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the PRSU award, the award vested as to 34,200 shares on March 1, 2022. F6 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the PRSU award, the award vested as to 34,200 shares on March 1, 2022. Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionPRSUs · Derivative	19,323	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-22-015756 · doc4.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the PRSU award, the award vested as to 29,904 shares on November 5, 2021. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the PRSU award, the award vested as to 29,904 shares on November 5, 2021. Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	Tax withholdingCommon Stock	20,792	$54.51	$1,133,371.92	Disclosure SEC source: 0001209191-22-015756 · doc4.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,218 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionCommon Stock	53,523	$0.00	$0.00	Disclosure SEC source: 0001209191-22-015756 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
February 10, 2022 Filed Feb 14, 2022 17:47 UTC	NUVASIVE INC NUVA · Entity 110002	GrantPRSUs · Derivative	19,323	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-22-009435 · doc4.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,323 Underlying: Common Stock · 19,323 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2019. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2021. On February 10, 2022, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 19,323 shares on March 1, 2022, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2019. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2021. On February 10, 2022, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 19,323 shares on March 1, 2022, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document
November 05, 2021 Filed Nov 9, 2021 17:50 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionPRSUs · Derivative	29,904	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-063680 · doc4.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the PRSU award, the award vested as to 29,904 shares on November 5, 2021. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the PRSU award, the award vested as to 29,904 shares on November 5, 2021. Read SEC document
November 05, 2021 Filed Nov 9, 2021 17:50 UTC	NUVASIVE INC NUVA · Entity 110002	Tax withholdingCommon Stock	12,343	$57.40	$708,488.20	Disclosure SEC source: 0001209191-21-063680 · doc4.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,487 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
November 05, 2021 Filed Nov 9, 2021 17:50 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionCommon Stock	29,904	$0.00	$0.00	Disclosure SEC source: 0001209191-21-063680 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
November 01, 2021 Filed Nov 3, 2021 17:50 UTC	NUVASIVE INC NUVA · Entity 110002	GrantPRSUs · Derivative	29,904	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-062759 · doc4.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,904 Underlying: Common Stock · 29,904 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on November 5, 2018. The award was granted subject to performance conditions based on the level of year-over-year improvement in the Issuer's non-GAAP earnings per share during the three-year performance period ended September 30, 2021. On November 1, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 29,904 shares on November 5, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on November 5, 2018. The award was granted subject to performance conditions based on the level of year-over-year improvement in the Issuer's non-GAAP earnings per share during the three-year performance period ended September 30, 2021. On November 1, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 29,904 shares on November 5, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document
June 25, 2021 Filed Jun 29, 2021 17:45 UTC	NUVASIVE INC NUVA · Entity 110002	SaleCommon Stock	5,000	$70.00	$350,000.00	Disclosure SEC source: 0001209191-21-043720 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,926 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document
June 21, 2021 Filed Jun 23, 2021 17:53 UTC	NUVASIVE INC NUVA · Entity 110002	SaleCommon Stock	5,000	$68.00	$340,000.00	Disclosure SEC source: 0001209191-21-042809 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,926 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:47 UTC	NUVASIVE INC NUVA · Entity 110002	GrantRSUs · Derivative	38,199	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-017134 · doc4.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,199 Underlying: Common Stock · 38,199 shares Expires not disclosed F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024. F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024. Read SEC document
November 05, 2020 Filed Nov 9, 2020 17:48 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionRSUs · Derivative	17,944	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-20-057490 · doc4.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the RSU award, the award vested as to 17,944 shares on each of November 5, 2019 and November 5, 2020. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the RSU award, the award vested as to 17,944 shares on each of November 5, 2019 and November 5, 2020. Read SEC document
November 05, 2020 Filed Nov 9, 2020 17:48 UTC	NUVASIVE INC NUVA · Entity 110002	Tax withholdingCommon Stock	7,891	$44.68	$352,569.88	Disclosure SEC source: 0001209191-20-057490 · doc4.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,926 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document
November 05, 2020 Filed Nov 9, 2020 17:48 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionCommon Stock	17,944	$0.00	$0.00	Disclosure SEC source: 0001209191-20-057490 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	GrantRSUs · Derivative	34,284	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-20-015515 · doc4.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,284 Underlying: Common Stock · 34,284 shares Expires not disclosed F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023. F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023. Read SEC document
November 05, 2019 Filed Nov 7, 2019 17:41 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionRSUs · Derivative	17,944	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-19-055714 · doc4.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,944 Underlying: Common Stock · 17,944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the RSU award, the award vested as to 17,944 shares on November 5, 2019 and will vest as to 17,944 shares on November 5, 2020. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the RSU award, the award vested as to 17,944 shares on November 5, 2019 and will vest as to 17,944 shares on November 5, 2020. Read SEC document
November 05, 2019 Filed Nov 7, 2019 17:41 UTC	NUVASIVE INC NUVA · Entity 110002	Tax withholdingCommon Stock	8,071	$70.90	$572,233.90	Disclosure SEC source: 0001209191-19-055714 · doc4.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,873 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document
November 05, 2019 Filed Nov 7, 2019 17:41 UTC	NUVASIVE INC NUVA · Entity 110002	Exercise / conversionCommon Stock	17,944	$0.00	$0.00	Disclosure SEC source: 0001209191-19-055714 · doc4.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document
March 01, 2019 Filed Mar 5, 2019 17:46 UTC	NUVASIVE INC NUVA · Entity 110002	GrantRSUs · Derivative	34,200	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-19-016817 · doc4.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2022. F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2022. Read SEC document
November 05, 2018 Filed Nov 7, 2018 17:58 UTC	NUVASIVE INC NUVA · Entity 110002	GrantRSUs · Derivative	35,888	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-18-057680 · doc4.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,888 Underlying: Common Stock · 35,888 shares Expires not disclosed F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the RSU award, the award will vest as to 17,944 shares on each of November 5, 2019 and November 5, 2020. F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on November 5, 2018. In accordance with the terms of the RSU award, the award will vest as to 17,944 shares on each of November 5, 2019 and November 5, 2020. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.